Myocardial Protection During Cardiotoxic Chemotherapy.

Witteles, Ronald M; Bosch, Xavier

Witteles, Ronald M; Bosch, Xavier.

Afiliação

Witteles RM; From Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (R.M.W.); Cardiology Department, Cardiovascular Institute, Hospital Clinic, Barcelona, Spain (X.B.); and Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain (X.B.).
Bosch X; From Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (R.M.W.); Cardiology Department, Cardiovascular Institute, Hospital Clinic, Barcelona, Spain (X.B.); and Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain (X.B.). xbosch@clinic.ub.es.

Circulation ; 132(19): 1835-45, 2015 Nov 10.

Article em En | MEDLINE | ID: mdl-26553713

Assuntos

Antineoplásicos/efeitos adversos; Cardiotônicos/uso terapêutico; Cardiotoxicidade/prevenção & controle; Cardiopatias/induzido quimicamente; Cardiopatias/prevenção & controle; Animais; Antraciclinas/efeitos adversos; Cardiotoxicidade/diagnóstico; Cardiopatias/diagnóstico; Humanos

Palavras-chave

cardiotoxicity; cardiovascular diseases; complications; drug therapy; neoplasms; prevention

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiotônicos / Cardiotoxicidade / Cardiopatias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2015

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google